GPT and metabolic dysfunction-associated steatotic liver disease: Understanding the strengths and weaknesses of ALT as a biomarker of histologic change is valuable for clinical care and early phase clinical trials in pediatric NAFLD in which ALT is utilized as an outcome in future.